- Home
- CRC vs AXSM Comparison
CRC vs AXSM Comparison
Compare CRC & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRC
- AXSM
- Stock Information
- Founded
- CRC 2014
- AXSM 2012
- Country
- CRC United States
- AXSM United States
- Employees
- CRC N/A
- AXSM N/A
- Industry
- CRC Oil & Gas Production
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- CRC Energy
- AXSM Health Care
- Exchange
- CRC Nasdaq
- AXSM Nasdaq
- Market Cap
- CRC 4.1B
- AXSM 4.0B
- IPO Year
- CRC N/A
- AXSM 2015
- Fundamental
- Price
- CRC $48.40
- AXSM $91.03
- Analyst Decision
- CRC Strong Buy
- AXSM Strong Buy
- Analyst Count
- CRC 7
- AXSM 14
- Target Price
- CRC $63.83
- AXSM $124.57
- AVG Volume (30 Days)
- CRC 661.5K
- AXSM 421.5K
- Earning Date
- CRC 10-30-2024
- AXSM 11-04-2024
- Dividend Yield
- CRC 3.22%
- AXSM N/A
- EPS Growth
- CRC N/A
- AXSM N/A
- EPS
- CRC 2.33
- AXSM N/A
- Revenue
- CRC $2,259,000,000.00
- AXSM $291,489,000.00
- Revenue This Year
- CRC $1.08
- AXSM $42.50
- Revenue Next Year
- CRC $23.56
- AXSM $69.28
- P/E Ratio
- CRC $20.73
- AXSM N/A
- Revenue Growth
- CRC N/A
- AXSM 59.73
- 52 Week Low
- CRC $43.09
- AXSM $55.02
- 52 Week High
- CRC $58.44
- AXSM $98.40
- Technical
- Relative Strength Index (RSI)
- CRC 43.79
- AXSM 55.83
- Support Level
- CRC $47.23
- AXSM $91.52
- Resistance Level
- CRC $50.01
- AXSM $96.56
- Average True Range (ATR)
- CRC 1.25
- AXSM 2.95
- MACD
- CRC -0.41
- AXSM 0.13
- Stochastic Oscillator
- CRC 22.46
- AXSM 44.47
About CRC California Resources Corporation
California Resources Corp is an independent oil and natural gas exploration and production company operating properties exclusively within California. It provides affordable and reliable energy in a safe and responsible manner, to support and enhance the quality of life of Californians and the local communities in which the company operates. It has some of the lowest carbon intensity production in the United States and is focused on maximizing the value of its land, mineral, and technical resources for decarbonization by developing carbon capture and storage (CCS) and other emissions-reducing projects.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.